You are here
Alerts
This page shows all our alerts. These are Safety alerts, Medicine shortage alerts and Product recalls. You can sort the list with the filters on the left, use the search bar or both.
For more information see Product safety.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Alert/Advisory (1118)
- Medicines safety (497)
- Medical devices safety (342)
- Shortages (74)
- Safety (51)
- Prescription medicines (43)
- Regulatory compliance (15)
- Listed medicines (14)
- Import and export (13)
- Over the counter (OTC) medicines (11)
- Complementary medicines (10)
- Therapeutic goods regulation (10)
- Blood safety (8)
- Australian Register of Therapeutic Goods (ARTG) (5)
- Non-prescription medicines (5)
- Advertising (3)
- Sunscreens (3)
- Breast implant hub (2)
- Labelling and packaging (2)
- Legislation (2)
- Assessed listed medicines (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Metal-on-metal hip replacement implants hub (1)
- Registered complementary medicines (1)
Type of content
Results for
"[search-keyword]"
Search
1317 result(s) found, displaying 1 to 25
-
Safety alertsConsumers and health professionals should be aware that counterfeit Ozempic-labelled pens have been imported into Australia. These pens may pose a serious health risk and should not be used. There are clear inconsistencies from the original product to look out for.
-
Medicine shortage alertsWe have made a new Serious Scarcity Substitution Instrument to help manage the shortage and upcoming discontinuation of Ryzodeg 70/30 FlexTouch insulin.
-
Medicine shortage alertsThe new KwikPen presentation of Mounjaro is now available but supply of all strengths of Mounjaro vials remains limited.
-
Medicine shortage alertsWe have been advised that Novo Nordisk will gradually discontinue some of its earlier generation insulin products over the next 2 years.
-
Medicine shortage alertsShortage resolved
-
Safety alertsWe have become aware of an increasing number of cases of liver injury reported in scientific literature, by consumers who had taken products containing Garcinia gummi-gutta.
-
Medicine shortage alertsPharmaceutical company Novo Nordisk has advised us that a new brand of semaglutide approved for chronic weight management, Wegovy, will be available in Australia from early August 2024.
-
-
Safety alertsRobust Extreme capsules pose a serious risk to your health and should not be taken.
-
Medicine shortage alertsShortage resolved
-
Safety alertsThe TGA has received reports of serious adverse events in infants and children who have been given compounded wind and colic preparations containing Atropa belladonna (belladonna).
-
Safety alertsRead our safety advisory about this ingredient's potential to cause severe allergic reactions including anaphylaxis.
-
Medicine shortage alertsDue to Oxynorm being reinstated in Australia and Ordine shortage extension
-
Medicine shortage alertsCurrent shortage of Vyvanse 20 mg and anticipated shortage of Vyvanse 60mg capsules.
-
Recall actionsThe affected bi-level positive airway pressure (BiPAP) devices may stop providing therapy on an intermittent or permanent basis and the ‘Ventilator Inoperative’ alarm will sound.
-
-
Safety alertsFluoxetine substitution instrument has been extended.
-
Medicine shortage alertsPharmacists can now substitute one Orencia 125 mg product for the other
-
Medicine shortage alertsFind out about the shortage of Orencia (abatacept) 125 mg/mL ClickJect autoinjector and prefilled syringe for subcutaneous injection.
-
Medicine shortage alertsAll strengths of Vyvanse capsules are now available.
-
Safety alertsDark Horse Capsules pose a serious risk to your health and should not be taken.
-
Recall actionsIf the dosing syringe is stiff and difficult to use, you may not be able to control the delivery of the medicine. This poses a risk of choking, especially for babies.
-
Medicine shortage alertsShortages of both Orencia (abatacept) 125 mg products, the ClickJect prefilled autoinjector and prefilled syringe for subcutaneous injection, are anticipated from early to mid-June 2024. Find out more.
-
Medicine shortage alertsThis shortage has been extended
-
Medicine shortage alertsThe shortage of Vyvanse 60 mg has been extended to 30 April 2024
Pages
- Current page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- …
- Next page Next ›
- Last page Last »